ranivisio
midas pharma gmbh - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - Øyemidler - ranivisio is indicated in adults for:• the treatment of neovascular (wet) age-related macular degeneration (amd)• the treatment of visual impairment due to diabetic macular oedema (dme)• the treatment of proliferative diabetic retinopathy (pdr)• the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)• the treatment of visual impairment due to choroidal neovascularisation (cnv).
indivina 1 mg / 2.5 mg
orion corporation orion pharma - Østradiolvalerat / medroksyprogesteronacetat - tablett - 1 mg / 2.5 mg
indivina 1 mg / 5 mg
orion corporation orion pharma - Østradiolvalerat / medroksyprogesteronacetat - tablett - 1 mg / 5 mg
indivina 2 mg / 5 mg
orion corporation orion pharma - Østradiolvalerat / medroksyprogesteronacetat - tablett - 2 mg / 5 mg
senstend
plethora pharma solutions limited - lidokain, prilocaine - for tidlig utløsning - anestetika - senstend er angitt for behandling av primær prematur ejakulasjon hos voksne menn.
atorvastatin pensa 10 mg
pensa pharma ab - atorvastatinkalsiumtrihydrat - tablett, filmdrasjert - 10 mg
atorvastatin pensa 20 mg
pensa pharma ab - atorvastatinkalsiumtrihydrat - tablett, filmdrasjert - 20 mg
atorvastatin pensa 40 mg
pensa pharma ab - atorvastatinkalsiumtrihydrat - tablett, filmdrasjert - 40 mg
atorvastatin pensa 80 mg
pensa pharma ab - atorvastatinkalsiumtrihydrat - tablett, filmdrasjert - 80 mg
hypericum stada -
stada arzneimittel ag - prikkperikum - kapsel, hard